DocDollars

Urovant Sciences Inc

CA · United States · Reporting entity ID 100000876823

Total reported 2019–2025
$9.21M
#517 of 2,960 reporting companies — 0% of all reported industry payments
$2.24M in general payments across 37,701 records, plus $6.97M in research funding across 1,070 records.

How it breaks down

General payments $2,244,225
Research funding $6,968,667

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Urovant Sciences Inc reported $9.21M to US doctors and teaching hospitals from 2019 to 2025, ranking #517 of 2,960 reporting companies. 76% of that was research funding and 24% general payments such as consulting, speaking, food and travel. 37,701 general payment records and 1,070 research records were filed.

Common questions about Urovant Sciences Inc

How much has Urovant Sciences Inc paid US doctors?

Urovant Sciences Inc reported $9,212,892 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,244,225 in general payments, $6,968,667 in research funding.

How does Urovant Sciences Inc rank among drug and device companies?

It ranks #517 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Urovant Sciences Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.